Related Experiment Video

Updated: May 14, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?

Tamera Jo Corte, Nicole S Goh, Ian N Glaspole

    Thorax
    |January 25, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
    03:38

    Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

    Published on: June 20, 2025

    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
    06:03

    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

    Published on: May 9, 2025

    Related Experiment Videos

    Last Updated: May 14, 2026

    Refined Murine Model of Idiopathic Pulmonary Fibrosis
    07:51

    Refined Murine Model of Idiopathic Pulmonary Fibrosis

    Published on: June 17, 2025

    Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
    03:38

    Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

    Published on: June 20, 2025

    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
    06:03

    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

    Published on: May 9, 2025

    Related Concept Videos

    COPD: Pathogenesis and Clinical Features01:20

    COPD: Pathogenesis and Clinical Features

    Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
    The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

    Articles linked to this work by shared authors, journal, and citation graph.

    Experiences of using portable oxygen concentrators delivering oxygen or air among people with fibrotic interstitial lung disease in Australia: a qualitative study.

    BMJ open·2026

    Deep-Learning Algorithm Diagnostic Support for Usual Interstitial Pneumonia Pattern Recognition in Fibrotic Interstitial Lung Disease.

    Respirology (Carlton, Vic.)·2026

    Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a multicentre, randomised, sham-controlled trial.

    The Lancet. Respiratory medicine·2026

    A randomised clinical trial of a digital self-management package for people with interstitial lung disease: the REBUILD-SM protocol.

    Respiratory research·2025

    International Stakeholder Engagement on Clinical Care and Research for Sleep Assessment and Nocturnal Hypoxemia in Pulmonary Fibrosis.

    Chest·2025

    Erratic tacrolimus levels at 6 to 12 months post-lung transplant predicts poor outcomes.

    JHLT open·2025

    End of rarity: the evolving burden of interstitial lung diseases in England - trends from a national population-based cohort study.

    Thorax·2026

    Stakeholder-informed prioritisation of HealthTech innovation across chronic respiratory disease: the HERON study.

    Thorax·2026

    PM2.5, O3 and survival gains from China's clean air actions among patients with lung cancer: a 20-year registry-based cohort study in Beijing.

    Thorax·2026

    Effects of obstructive sleep apnoea treatment on cardiovascular and sleep health in bed partners: the sleep partners clinical trial.

    Thorax·2026

    Systematic misclassification of lung function in Indian adolescents using GLI-2012 reference equations: evidence from the multicity APEAL cohort.

    Thorax·2026

    International epidemiology of antimicrobial resistance in people living with chronic lung infection.

    Thorax·2026

    MAGEA6 Promoted Gastric Cancer Progression by Activating Mitophagy.

    Molecular carcinogenesis·2026

    NET-Associated Inflammatory Markers in Head and Neck Squamous Cell Carcinoma: Bioinformatic Prioritization and Exploratory Serum Assessment in Patients Undergoing Radiotherapy.

    Molecular carcinogenesis·2026

    Impact of PD-1 and PD-L1 inhibitors on patient-reported outcomes in esophageal squamous cell carcinoma: a systematic review of clinical trials.

    Current medical research and opinion·2026

    Perfusion beyond Margin in Hepatocellular Carcinoma: A Contrast-enhanced US Feature Related to Tumor Invasiveness and Prognosis.

    Radiology·2026

    Prognostic Value of Primary Tumor and Immune Organ Metabolic Parameters Derived from Pretreatment 18F-FDG PET/CT in Gastric Adenocarcinoma: A Retrospective Survival Analysis.

    Molecular imaging and radionuclide therapy·2026

    Cell-based polygenic risk scores predict clinical progression and prioritize network-based therapeutic targets in Alzheimer's disease.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us